- 12.29.2023
- Updates
BENZINGA: Kentucky's Promising Opioid Addiction Treatment Initiative Stalls As New AG Ousts Leading Advocate
Once a promising pioneer state in ibogaine research for the treatment of opioid use disorder, Kentucky’s appointment of Attorney General Russell Coleman has brought about the removal of Bryan Hubbard.
- 12.28.2023
- Updates
- Press Releases
PRESS RELEASE: VETS and Rep. Dan Crenshaw Celebrate Bi-Partisan Support for NDAA Bill that Includes Grants for Research in Psychedelic Treatment
Collaboration Helps Bring U.S. Rep. Dan Crenshaw's Douglas Mike Day Psychedelic Therapy to Save Lives Act, legislation that will direct the Defense Department to create grants for studying psychedelic treatments for active duty service members.
- 12.21.2023
- Updates
MDMA therapy for wartrauma in civilians and veterans, by Amber Capone & Johnathan M. Lubecky
The discussion highlights VETS' mission and the advocacy work of Amber, Jon, and the full team to advance research and access for veterans to receive PAT (MDMA and ibogaine).
- 12.18.2023
- Updates
Military Times: First-ever provision for psychedelic studies included in defense bill
A first-ever provision included in this year’s defense policy bill enables studies to analyze the effects of psychedelics on troops suffering from various medical issues.
THE INTERCEPT: CONGRESS IS PUSHING REVOLUTIONARY RESEARCH ON PSYCHEDELIC TREATMENTS FOR THE MILITARY
A provision in the annual defense bill would have the Pentagon run clinical trials for members of the military with post-traumatic stress disorder.